Tadahiro Shoji Selected Research

Tadahiro Shoji Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 06/2008
16	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 06/2008
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 04/2010
7	Carcinoma (Carcinomatosis) 12/2021 - 06/2008
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2021 - 06/2008
6	Disease Progression 01/2022 - 10/2012
3	Ovarian Epithelial Carcinoma 09/2019 - 12/2011
3	Neutropenia 01/2018 - 08/2013
3	Ascites 07/2014 - 06/2008
2	Fistula 01/2022 - 08/2018
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2021 - 02/2014
2	Lung Neoplasms (Lung Cancer) 11/2020 - 09/2019
2	Hypertension (High Blood Pressure) 08/2018 - 01/2018
2	Neoplasm Metastasis (Metastasis) 08/2018 - 01/2018
2	Carcinosarcoma 06/2015 - 12/2014
2	Lymphatic Metastasis 04/2015 - 06/2008
2	Anemia 08/2013 - 12/2011
2	Endometrial Neoplasms (Endometrial Cancer) 01/2012 - 11/2007
1	Hypoxia (Hypoxemia) 11/2020
1	Signet Ring Cell Carcinoma 03/2020
1	Colorectal Neoplasms (Colorectal Cancer) 09/2019
1	Thrombosis (Thrombus) 08/2018
1	Proteinuria 08/2018
1	Intestinal Perforation 08/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Leiomyosarcoma 01/2018
1	Surgical Blood Loss 12/2016
1	Nausea 03/2015
1	Vomiting 03/2015
1	Sarcoma (Soft Tissue Sarcoma) 12/2014
1	Adenocarcinoma 04/2014
1	Fatigue 08/2013
1	Diarrhea 08/2013
1	Thrombocytopenia (Thrombopenia) 08/2013
1	Constipation 10/2012
1	Carcinoid Tumor (Carcinoid) 10/2012
1	Takotsubo Cardiomyopathy 01/2012

Drug/Important Bio-Agent (IBA)

14	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 11/2010
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 12/2011
10	PlatinumIBA 01/2022 - 01/2011
9	Irinotecan (Camptosar)FDA LinkGeneric 08/2017 - 04/2010
7	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2015
7	taxaneIBA 10/2019 - 06/2008
4	Docetaxel (Taxotere)FDA Link 07/2021 - 11/2010
4	Cisplatin (Platino)FDA LinkGeneric 08/2016 - 04/2010
3	liposomal doxorubicin (Doxil)FDA Link 10/2019 - 05/2014
3	Gemcitabine FDA Link 10/2019 - 01/2013
3	nedaplatinIBA 08/2016 - 06/2008
3	Proteins (Proteins, Gene)FDA Link 10/2015 - 06/2008
2	AntigensIBA 01/2022 - 07/2016
2	Angiogenesis InhibitorsIBA 03/2020 - 09/2019
2	1-dodecylpyridoxal (PLD)IBA 08/2017 - 05/2014
2	squamous cell carcinoma-related antigenIBA 07/2016 - 04/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 06/2012
1	niraparibIBA 05/2021
1	olaparibIBA 05/2021
1	Peptides (Polypeptides)IBA 11/2020
1	EpitopesIBA 11/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2020
1	Growth Factor ReceptorsIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 03/2020
1	Tumor Biomarkers (Tumor Markers)IBA 03/2020
1	4-boronic acid benzophenoneIBA 09/2019
1	pazopanib FDA Link 01/2018
1	veliparibIBA 11/2017
1	GadoliniumIBA 09/2017
1	VimentinIBA 09/2017
1	Estrogen ReceptorsIBA 09/2017
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 09/2017
1	DesminIBA 09/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2017
1	Carcinoembryonic AntigenIBA 07/2016
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2015
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 05/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2015
1	Palonosetron (Aloxi)FDA Link 03/2015
1	AntiemeticsIBA 03/2015
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 07/2014
1	Dihydrotachysterol (AT 10)IBA 07/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2014
1	Everolimus FDA Link 01/2014
1	TOR Serine-Threonine KinasesIBA 01/2014
1	Peptide YYIBA 10/2012
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2012

Therapy/Procedure

21	Therapeutics 01/2022 - 11/2010
15	Drug Therapy (Chemotherapy) 01/2022 - 12/2011
7	Hysterectomy 03/2020 - 02/2014
7	Neoadjuvant Therapy 12/2016 - 04/2010
4	Chemoradiotherapy 05/2021 - 06/2008
3	Radiotherapy 01/2022 - 06/2008
3	Immunotherapy 11/2020 - 09/2019
2	Salpingo-oophorectomy 03/2020 - 12/2014
2	Combination Drug Therapy (Combination Chemotherapy) 08/2018 - 01/2011
1	Adjuvant Chemotherapy 05/2021
1	TP protocol 08/2018
1	Brachytherapy 08/2018
1	Radiofrequency Therapy 01/2018
1	Operative Time 12/2016
1	Drug Tapering 05/2014